Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-09-16
1988-06-14
Siegel, Alan
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514253, 514321, 5142338, 544144, 544373, 546198, 548453, A61K 31445, C07D48702
Patent
active
047512318
ABSTRACT:
Thieno[2,3-b]pyrrole-5-sulfonamides are carbonic anhydrase inhibitors useful in the treatment of elevated intraocular pressure and glaucoma.
REFERENCES:
patent: 4477466 (1984-10-01), Shepard
patent: 4668697 (1987-05-01), Shepard
Snyder et al., J. Amer. Chem. Soc., 1957, 79, 2556.
Kumar et al., Ind. J. Chem., 1981, 20B, 271.
Halczenko Wasyl
Hartman George D.
Merck & Co. , Inc.
Nicholson William H.
Siegel Alan
Sudol Michael C.
LandOfFree
Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-505303